君乐宝启动港股上市进程，全产业链支撑盈利能力显著跃升

Core Viewpoint - Junlebao Dairy Group, a leading comprehensive dairy enterprise in China, has submitted its main board listing application to the Hong Kong Stock Exchange, marking a new phase of capitalized development after 30 years in the industry [1] Financial Performance - Junlebao's total revenue increased from 17.5 billion yuan in 2023 to 19.8 billion yuan in 2024, with 15.1 billion yuan achieved in the first three quarters of 2025, indicating a strong growth trend [3] - Adjusted net profit surged from 600 million yuan in 2023 to 1.16 billion yuan in 2024, with net profit margin improving from 3.4% to 5.9%, further rising to 6.2% in the first nine months of 2025 [3] - The company's operational quality has significantly improved due to integrated operations across the entire industry chain, product structure optimization, and digital transformation [3] Market Position and Product Strategy - Junlebao has established a strong position in the low-temperature liquid milk segment, which is the fastest-growing area in the Chinese dairy market, serving as the core engine for its performance growth [3] - The "Yuexianhuo" brand captured a 24.0% market share in 2024, becoming the top brand in China's high-end fresh milk market, while the "Jianchun" brand successfully created a new category with its "zero sugar" positioning, leading the low-temperature yogurt market [3] Market Expansion and Future Outlook - The company has built a sales network covering all 31 provincial-level administrative regions in China, reaching approximately 2,200 districts and counties, and collaborating with over 5,500 distributors [4] - Junlebao's products are available at around 400,000 retail terminals for low-temperature liquid milk, with rapid growth in high-consumption markets such as East and South China [4] - The upcoming listing is expected to raise funds for capacity upgrades, brand building, and R&D innovation, further solidifying its market leadership and initiating a new chapter of high-quality development [4]